Liver Cancer

Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma

Publish Date December 18, 2020

[Journal of Hepatocellular Carcinoma] Researchers at UT MD Anderson Cancer Center assessed the value of chest, abdominal, and pelvic CT in the surveillance of patients with HCC, and the potential drawbacks to the practice.

Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer

Publish Date November 2, 2020

Patients from rural regions, lower-income households have more advanced stage at diagnosis of HCC.

Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Publish Date September 18, 2020

[Cancer Management and Research] Researchers present a simple classification method for assessing fatigue, which is proven to be a prognostic marker of TTP and OS in patients with HCC.

FDA Denies Accelerated Approval of Keytruda Plus Lenvima for Unresectable HCC

By

Brian Park, PharmD

Publish Date July 14, 2020

In the CRL, the FDA stated that the data from KEYNOTE-524/Study 116 did not demonstrate a meaningful advantage over available therapies for unresectable or metastatic HCC.

Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma

Publish Date June 26, 2020

[Cancer Management and Research] Researchers sought to determine if apatinib-related hypertension was a predictor of drug efficacy in patients with advanced HCC.

Liver Cancer Clinical Trials

NSCLC: Study Assesses Adjuvant Chemo Decision-making Role Preferences

Clinical Trial: Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Clinical Trials: Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Clinical Trial: Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Clinical Trial: Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms.